{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:18:44Z","timestamp":1780586324137,"version":"3.54.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11906-025-01343-6","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:52:34Z","timestamp":1760619154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Obesity, Hypertension and Brain Health"],"prefix":"10.1007","volume":"27","author":[{"given":"Kasim","family":"Qureshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad U.","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1181-614X","authenticated-orcid":false,"given":"Philip B.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"1343_CR1","volume":"6","author":"PB Gorelick","year":"2024","unstructured":"Gorelick PB, Sorond FA. What is brain health? Cereb Circ. 2024;6:100190.","journal-title":"Cereb Circ"},{"key":"1343_CR2","doi-asserted-by":"crossref","unstructured":"Filley C, Bigler E. Neuroanatomy for the Neuropsychologist. In: Textbook of Clinical Neuropscyhology, 2nd edition. New York: Taylor & Francis, 2018; pp. 62\u201390.","DOI":"10.4324\/9781315271743-6"},{"issue":"11","key":"1343_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S1474-4422(23)00318-6","volume":"22","author":"PB Gorelick","year":"2023","unstructured":"Gorelick PB, Sorond FA. Advancing our knowledge about cerebral small vessel diseases. Lancet Neurol. 2023;22(11):972\u20133.","journal-title":"Lancet Neurol"},{"key":"1343_CR4","volume":"6","author":"PB Gorelick","year":"2024","unstructured":"Gorelick PB, Hainsworth AH, Wallin A. What will it take to achieve brain health globally? Cerebral Circulation. 2024;6:100209.","journal-title":"Cerebral Circulation"},{"issue":"10","key":"1343_CR5","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1161\/STR.0000000000000148","volume":"48","author":"PB Gorelick","year":"2017","unstructured":"Gorelick PB, Furie KL, Iadecola C, Smith EE, Waddy SP, Lloyd-Jones DM, et al. Defining optimal brain health in adults: a presidential advisory from the American Heart Association\/American Stroke Association. Stroke. 2017;48(10):e284-303.","journal-title":"Stroke"},{"issue":"10452","key":"1343_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet. 2024;404(10452):572\u2013628.","journal-title":"Lancet"},{"issue":"12","key":"1343_CR7","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1161\/STR.0000000000000476","volume":"55","author":"FD Testai","year":"2024","unstructured":"Testai FD, Gorelick PB, Chuang PY, Dai X, Furie KL, Gottesman RF, et al. Cardiac contributions to brain health: a scientific statement from the American heart association. Stroke. 2024;55(12):e425-38.","journal-title":"Stroke"},{"issue":"1","key":"1343_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cger.2022.07.007","volume":"39","author":"S Mahinrad","year":"2023","unstructured":"Mahinrad S, Sorond F, Gorelick PB. The role of vascular risk factors in cognitive impairment and dementia and prospects for prevention. Clin Geriatr Med. 2023;39(1):123\u201334.","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"1343_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jnc.14113","volume":"144","author":"PB Gorelick","year":"2018","unstructured":"Gorelick PB. Prevention of cognitive impairment: scientific guidance and windows of opportunity. J Neurochem. 2018;144(5):609\u201316.","journal-title":"J Neurochem"},{"issue":"7","key":"1343_CR10","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1002\/alz.12935","volume":"19","author":"S Mahinrad","year":"2023","unstructured":"Mahinrad S, Bennett DA, Sorond FA, Gorelick PB. Blood pressure variability, dementia, and role of antihypertensive medications in older adults. Alzheimers Dement. 2023;19(7):2966\u201374.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1343_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1192\/bjp.2019.156","volume":"216","author":"R Peters","year":"2020","unstructured":"Peters R, Peters J, Booth A, Anstey KJ. Trajectory of blood pressure, body mass index, cholesterol and incident dementia: systematic review. Br J Psychiatry. 2020;216(1):16\u201328.","journal-title":"Br J Psychiatry"},{"key":"1343_CR12","unstructured":"Organization WH. Optimizing brain health across the life course: WHO position paper. World Health Organization. 2022; p. 65."},{"issue":"7","key":"1343_CR13","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/alz.12478","volume":"18","author":"A Avan","year":"2022","unstructured":"Avan A, Hachinski V, the Brain Health Learn and Act Group. Brain health: key to health, productivity, and well-being. Alzheimers Dement. 2022;18(7):1396\u2013407.","journal-title":"Alzheimers Dement"},{"issue":"13","key":"1343_CR14","first-page":"570","volume":"101","author":"NS Rost","year":"2023","unstructured":"Rost NS, Salinas J, Jordan JT, Banwell B, Correa DJ, Said RR, et al. The brain health imperative in the 21st Century\u2014A. Call Action Neurol. 2023;101(13):570\u20139.","journal-title":"Call Action Neurol"},{"issue":"12","key":"1343_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S1474-4422(24)00448-4","volume":"23","author":"The Lancet Neurology null","year":"2024","unstructured":"The Lancet Neurology null. United action is needed to prioritise brain health. Lancet Neurol. 2024;23(12):1169.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1343_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, Servili C, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet Neurol. 2024;23(4):344\u201381.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1343_CR17","doi-asserted-by":"publisher","first-page":"e220949","DOI":"10.1001\/jamahealthforum.2022.0949","volume":"3","author":"K Bibbins-Domingo","year":"2022","unstructured":"Bibbins-Domingo K, Fernandez A. Physician\u2013public health practitioners\u2014the missing academic medicine career track. JAMA Health Forum. 2022;3(3):e220949.","journal-title":"JAMA Health Forum"},{"issue":"1","key":"1343_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41380-020-00918-w","volume":"26","author":"E Smith","year":"2021","unstructured":"Smith E, Ali D, Wilkerson B, Dawson WD, Sobowale K, Reynolds C, et al. A brain capital grand strategy: toward economic reimagination. Mol Psychiatry. 2021;26(1):3\u201322.","journal-title":"Mol Psychiatry"},{"issue":"10440","key":"1343_CR19","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"M Brauer","year":"2024","unstructured":"Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"key":"1343_CR20","doi-asserted-by":"crossref","unstructured":"GBD2021ABMIC. Global, regional, and National prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the global burden of disease study 2021. Lancet. 2025;405(10481):813\u201338.","DOI":"10.1016\/S0140-6736(25)00355-1"},{"issue":"9","key":"1343_CR21","doi-asserted-by":"publisher","first-page":"e009773","DOI":"10.1136\/bmjgh-2022-009773","volume":"7","author":"A Okunogbe","year":"2022","unstructured":"Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022;7(9):e009773.","journal-title":"BMJ Glob Health"},{"issue":"10","key":"1343_CR22","doi-asserted-by":"publisher","first-page":"e4260","DOI":"10.1210\/clinem\/dgab135","volume":"106","author":"F Morys","year":"2021","unstructured":"Morys F, Dadar M, Dagher A. Association between midlife obesity and its metabolic consequences, cerebrovascular disease, and cognitive decline. J Clin Endocrinol Metab. 2021;106(10):e4260-74.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1343_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s11033-025-10509-z","volume":"52","author":"Y Dhurandhar","year":"2025","unstructured":"Dhurandhar Y, Tomar S, Das A, Prajapati JL, Singh AP, Bodake SH, et al. Chronic inflammation in obesity and neurodegenerative diseases: exploring the link in disease onset and progression. Mol Biol Rep. 2025;52(1):424.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"1343_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/obr.12629","volume":"19","author":"S Alford","year":"2018","unstructured":"Alford S, Patel D, Perakakis N, Mantzoros CS. Obesity as a risk factor for Alzheimer\u2019s disease: weighing the evidence. Obes Rev. 2018;19(2):269\u201380.","journal-title":"Obes Rev"},{"key":"1343_CR25","doi-asserted-by":"publisher","first-page":"761456","DOI":"10.3389\/fnins.2021.761456","volume":"15","author":"L Olsthoorn","year":"2021","unstructured":"Olsthoorn L, Vreeken D, Kiliaan AJ. Gut microbiome, inflammation, and cerebrovascular function: link between obesity and cognition. Front Neurosci. 2021;15:761456.","journal-title":"Front Neurosci"},{"issue":"9","key":"1343_CR26","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41430-020-0607-6","volume":"74","author":"L Crovesy","year":"2020","unstructured":"Crovesy L, Masterson D, Rosado EL. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr. 2020;74(9):1251\u201362.","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"1343_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S2213-8587(25)00004-X","volume":"13","author":"The Lancet Diabetes Endocrinology null","year":"2025","unstructured":"The Lancet Diabetes Endocrinology null. Redefining obesity: advancing care for better lives. Lancet Diabetes Endocrinol. 2025;13(2):75.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1343_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/oby.24239","volume":"33","author":"J Luo","year":"2025","unstructured":"Luo J, Wang Y, Mao J, Yuan Y, Luo P, Wang G, et al. Features, functions, and associated diseases of visceral and ectopic fat: a comprehensive review. Obesity. 2025;33(5):825\u201338.","journal-title":"Obesity"},{"issue":"11","key":"1343_CR29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213630","volume":"104","author":"Hwen Chen","year":"2025","unstructured":"Chen Hwen, Wang SA, Xu ZY, Shao ZH, Zhong Q, Wei YF, et al. Association of predicted visceral fat percentage with dementia risk in older adults. Neurology. 2025;104(11):e213630.","journal-title":"Neurology"},{"key":"1343_CR30","volume":"6","author":"L Sherlock","year":"2024","unstructured":"Sherlock L, Lee SF, Cukierman-Yaffe T, Leong D, Gerstein HC, Bosch J, et al. Visit-to-visit variability in multiple biological measurements and cognitive performance and risk of cardiovascular disease: a cohort study. Cereb Circ. 2024;6:100223.","journal-title":"Cereb Circ"},{"issue":"4","key":"1343_CR31","doi-asserted-by":"publisher","first-page":"e210247","DOI":"10.1212\/WNL.0000000000210247","volume":"104","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Moran C, Murray AM, Zoungas S, Magnussen C, Chong TTJ, et al. Association of year-to-year lipid variability with risk of cognitive decline and dementia in community-dwelling older adults. Neurology. 2025;104(4):e210247.","journal-title":"Neurology"},{"key":"1343_CR32","doi-asserted-by":"crossref","unstructured":"Qureshi D, Luben R, Hayat S, Talarico R, Allen NE, Ku\u017ama E et al. Role of age and exposure duration in the association between metabolic syndrome and risk of incident dementia: a prospective cohort study. The Lancet Healthy Longevity [Internet]. 2024 Dec 1 [cited 2025 Jul 10];5(12). Available from: https:\/\/www.thelancet.com\/journals\/lanhl\/article\/PIIS2666-7568(24)00178-8\/fulltext","DOI":"10.1016\/j.lanhl.2024.100652"},{"issue":"9","key":"1343_CR33","doi-asserted-by":"publisher","first-page":"e213581","DOI":"10.1212\/WNL.0000000000213581","volume":"104","author":"PH Lazzaris Coelho","year":"2025","unstructured":"Lazzaris Coelho PH, Gomes Goncalves N, Santos IS, Goulart AC, Barreto SM, Giatti L, et al. Association of early- to midlife weight trajectories with mid- to late-life cognitive decline in the ELSA-Brasil study. Neurology. 2025;104(9):e213581.","journal-title":"Neurology"},{"issue":"1","key":"1343_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/brain\/awae198","volume":"148","author":"ST Chiesa","year":"2025","unstructured":"Chiesa ST, Rader L, Garfield V, Foote I, Suri S, Davey Smith G, et al. Childhood adiposity underlies numerous adult brain traits commonly attributed to midlife obesity. Brain. 2025;148(1):133\u201342.","journal-title":"Brain"},{"issue":"6","key":"1343_CR35","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/alz.12839","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, Liu C, Ang TFA, Au R. BMI decline patterns and relation to dementia risk across four decades of follow-up in the Framingham study. Alzheimers Dement. 2023;19(6):2520\u20137.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1343_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/oby.24208","volume":"33","author":"Z Liang","year":"2025","unstructured":"Liang Z, Qin H, Su B, Bao Y, Vitiello MV, Hu G, et al. Trajectories of general and central obesity beyond middle age in relation to late-life cognitive decline and dementia. Obesity. 2025;33(2):405\u201315.","journal-title":"Obesity"},{"issue":"12","key":"1343_CR37","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jamapsychiatry.2022.3446","volume":"79","author":"J Guo","year":"2022","unstructured":"Guo J, Wang J, Dove A, Chen H, Yuan C, Bennett DA, et al. Body mass index trajectories preceding incident mild cognitive impairment and dementia. JAMA Psychiatr. 2022;79(12):1180\u20137.","journal-title":"JAMA Psychiatr"},{"issue":"7","key":"1343_CR38","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/nu15071795","volume":"15","author":"I Grapsa","year":"2023","unstructured":"Grapsa I, Mamalaki E, Ntanasi E, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, et al. Longitudinal examination of body mass index and cognitive function in older adults: the HELIAD study. Nutrients. 2023;15(7):1795.","journal-title":"Nutrients"},{"key":"1343_CR39","doi-asserted-by":"publisher","first-page":"119415","DOI":"10.1016\/j.neuroimage.2022.119415","volume":"259","author":"Y Zeighami","year":"2022","unstructured":"Zeighami Y, Dadar M, Daoust J, Pelletier M, Biertho L, Bouvet-Bouchard L, et al. Impact of weight loss on brain age: improved brain health following bariatric surgery. Neuroimage. 2022;259:119415.","journal-title":"Neuroimage"},{"issue":"20","key":"1343_CR40","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity management in adults: a review. JAMA. 2023;330(20):2000\u201315.","journal-title":"JAMA"},{"key":"1343_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106159","volume":"173","author":"HCT Au","year":"2025","unstructured":"Au HCT, Lam PH, Lim PK, McIntyre RS. Role of glucagon-like peptide-1 on amyloid, tau, and \u03b1-synuclein: target engagement and rationale for the development in neurodegenerative disorders. Neurosci Biobehav Rev. 2025;173:106159.","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"1343_CR42","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1161\/STR.0000000000000367","volume":"52","author":"RM Lazar","year":"2021","unstructured":"Lazar RM, Howard VJ, Aparicio HJ, Jordan LC, Kernan WN, Levine DA, et al. A primary care agenda for brain health. Stroke. 2021;52(6):e295\u2013308.","journal-title":"Stroke"},{"issue":"7","key":"1343_CR43","doi-asserted-by":"publisher","first-page":"e2520011","DOI":"10.1001\/jamanetworkopen.2025.20011","volume":"8","author":"P Correa-Burrows","year":"2025","unstructured":"Correa-Burrows P, Burrows R, Albala C, Sep\u00falveda C, Salech F, Troncoso R, et al. Long-term obesity and biological aging in young adults. JAMA Netw Open. 2025;8(7):e2520011.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1343_CR44","doi-asserted-by":"publisher","first-page":"e2022060641","DOI":"10.1542\/peds.2022-060641","volume":"151","author":"SE Hampl","year":"2023","unstructured":"Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, et al. Executive summary: clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2):e2022060641.","journal-title":"Pediatrics"},{"issue":"24","key":"1343_CR45","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1001\/jama.2024.24026","volume":"332","author":"KG Volpp","year":"2024","unstructured":"Volpp KG. Obesity prevention at an early age: progress, but a long way to go. JAMA. 2024;332(24):2063\u20134.","journal-title":"JAMA"},{"issue":"4","key":"1343_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"10304","key":"1343_CR47","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"B Zhou","year":"2021","unstructured":"Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380.","journal-title":"Lancet"},{"issue":"6","key":"1343_CR48","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441\u201350.","journal-title":"Circulation"},{"issue":"7","key":"1343_CR49","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1097\/HJH.0b013e32832a9ba3","volume":"27","author":"TA Gaziano","year":"2009","unstructured":"Gaziano TA, Bitton A, Anand S, Weinstein MC. Hypertension for the IS of. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27(7):1472.","journal-title":"J Hypertens"},{"key":"1343_CR50","doi-asserted-by":"publisher","unstructured":"Canavan M, O\u2019Donnell MJ, Hypertension, Impairment C. A Review of Mechanisms and Key Concepts. Front Neurol [Internet]. 2022 Feb 4 [cited 2025 Jul 7];13. Available from: https:\/\/www.frontiersin.org\/journals\/neurology\/articles\/https:\/\/doi.org\/10.3389\/fneur.2022.821135\/full","DOI":"10.3389\/fneur.2022.821135\/full"},{"issue":"8","key":"1343_CR51","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/0271678X17728162","volume":"38","author":"L Zhao","year":"2018","unstructured":"Zhao L, Biesbroek JM, Shi L, Liu W, Kuijf HJ, Chu WW, et al. Strategic infarct location for post-stroke cognitive impairment: a multivariate lesion-symptom mapping study. J Cereb Blood Flow Metab. 2018;38(8):1299\u2013311.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"1343_CR52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689\u2013701.","journal-title":"Lancet Neurol"},{"issue":"10","key":"1343_CR53","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","volume":"17","author":"Z Ungvari","year":"2021","unstructured":"Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, et al. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol. 2021;17(10):639\u201354.","journal-title":"Nat Rev Nephrol"},{"issue":"13","key":"1343_CR54","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa022066","volume":"348","author":"SE Vermeer","year":"2003","unstructured":"Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215\u201322.","journal-title":"N Engl J Med"},{"issue":"1\u20133","key":"1343_CR55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000285518","volume":"7","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA. Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases. Neurodegener Dis. 2010;7(1\u20133):112\u20135.","journal-title":"Neurodegener Dis"},{"issue":"12","key":"1343_CR56","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12(12):723\u201338.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1343_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0197-4580(00)00106-8","volume":"21","author":"H Petrovitch","year":"2000","unstructured":"Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging study. Neurobiol Aging. 2000;21(1):57\u201362.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1343_CR58","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamaneurol.2013.1342","volume":"70","author":"KM Rodrigue","year":"2013","unstructured":"Rodrigue KM, Rieck JR, Kennedy KM, Devous MD, Diaz-Arrastia R, Park DC. Risk factors for \u03b2-amyloid deposition in healthy aging. JAMA Neurol. 2013;70(5):600\u20136.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1343_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamapediatrics.2024.4368","volume":"179","author":"Y Meng","year":"2025","unstructured":"Meng Y, Sharman JE, Iiskala F, Wu F, Juonala M, Pahkala K, et al. Tracking and transition probability of blood pressure from childhood to midadulthood. JAMA Pediatr. 2025;179(1):34\u201345.","journal-title":"JAMA Pediatr"},{"issue":"18","key":"1343_CR60","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1001\/jama.2020.20122","volume":"324","author":"US Preventive Services Task Force","year":"2020","unstructured":"US Preventive Services Task Force. Screening for high blood pressure in children and adolescents: US preventive services task force recommendation statement. JAMA. 2020;324(18):1878\u201383.","journal-title":"JAMA"},{"issue":"3","key":"1343_CR61","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904.","journal-title":"Pediatrics"},{"issue":"6","key":"1343_CR62","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/HYPERTENSIONAHA.118.12469","volume":"73","author":"T Du","year":"2019","unstructured":"Du T, Fernandez C, Barshop R, Chen W, Urbina EM, Bazzano LA. 2017 pediatric hypertension guidelines improve prediction of adult cardiovascular outcomes. Hypertension. 2019;73(6):1217\u201323.","journal-title":"Hypertension"},{"issue":"3","key":"1343_CR63","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/HYPERTENSIONAHA.124.23985","volume":"82","author":"SMJ Cho","year":"2025","unstructured":"Cho SMJ, Urbut S, Ruan Y, Bhatnagar A, Ganesh S, Hornsby WE, et al. East and South Asian-specific blood pressure trajectories and cardiovascular disease. Hypertension. 2025;82(3):520\u201331.","journal-title":"Hypertension"},{"key":"1343_CR64","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpeds.2016.08.076","volume":"180","author":"MB Lande","year":"2017","unstructured":"Lande MB, Batisky DL, Kupferman JC, Samuels J, Hooper SR, Falkner B, et al. Neurocognitive function in children with primary hypertension. J Pediatr. 2017;180:148\u2013e1551.","journal-title":"J Pediatr"},{"issue":"6","key":"1343_CR65","doi-asserted-by":"publisher","first-page":"e1425","DOI":"10.1542\/peds.2010-1899","volume":"126","author":"HR Adams","year":"2010","unstructured":"Adams HR, Szilagyi PG, Gebhardt L, Lande MB. Learning and attention problems among children with pediatric primary hypertension. Pediatrics. 2010;126(6):e1425-1429.","journal-title":"Pediatrics"},{"issue":"15","key":"1343_CR66","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1161\/CIRCULATIONAHA.113.004798","volume":"129","author":"K Yaffe","year":"2014","unstructured":"Yaffe K, Vittinghoff E, Pletcher MJ, Hoang TD, Launer LJ, Whitmer RA, et al. Early adult to midlife cardiovascular risk factors and cognitive function. Circulation. 2014;129(15):1560\u20137.","journal-title":"Circulation"},{"issue":"12","key":"1343_CR67","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400193","volume":"3","author":"B Fishman","year":"2024","unstructured":"Fishman B, Vinograd A, Tsur AM, Bardugo A, Bendor CD, Libruder C, et al. Adolescent blood pressure and early age stroke. NEJM Evid. 2024;3(12):EVIDoa2400193.","journal-title":"NEJM Evid"},{"issue":"10","key":"1343_CR68","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jamaneurol.2014.1646","volume":"71","author":"RF Gottesman","year":"2014","unstructured":"Gottesman RF, Schneider ALC, Albert M, Alonso A, Bandeen-Roche K, Coker L, et al. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol. 2014;71(10):1218\u201327.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1343_CR69","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/jamainternmed.2021.7009","volume":"182","author":"JW van Dalen","year":"2022","unstructured":"van Dalen JW, Brayne C, Crane PK, Fratiglioni L, Larson EB, Lobo A, et al. Association of systolic blood pressure with dementia risk and the role of age, U-shaped associations, and mortality. JAMA Intern Med. 2022;182(2):142\u201352.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1343_CR70","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/HYPERTENSIONAHA.119.13664","volume":"74","author":"RAA de Heus","year":"2019","unstructured":"de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen JAHR, for the NILVAD Study Group. Blood pressure variability and progression of clinical Alzheimer disease. Hypertension. 2019;74(5):1172\u201380.","journal-title":"Hypertension"},{"issue":"1","key":"1343_CR71","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013841","volume":"9","author":"PJ Tully","year":"2020","unstructured":"Tully PJ, Yano Y, Launer LJ, Kario K, Nagai M, Mooijaart SP, et al. Association between blood pressure variability and cerebral small\u2010vessel disease: a systematic review and meta\u2010analysis. J Am Heart Assoc. 2020;9(1):e013841.","journal-title":"J Am Heart Assoc"},{"issue":"9137","key":"1343_CR72","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","volume":"352","author":"F Forette","year":"1998","unstructured":"Forette F, Seux ML, Staessen JA, Thijs L, Birkenh\u00e4ger WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352(9137):1347\u201351.","journal-title":"Lancet"},{"issue":"6","key":"1343_CR73","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","volume":"321","author":"The SPRINT MIND Investigators for the SPRINT Research Group","year":"2019","unstructured":"The SPRINT MIND Investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: A randomized clinical trial. JAMA. 2019;321(6):553\u201361.","journal-title":"JAMA"},{"issue":"3","key":"1343_CR74","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/HYPERTENSIONAHA.122.20112","volume":"80","author":"C Jiang","year":"2023","unstructured":"Jiang C, Li S, Wang Y, Lai Y, Bai Y, Zhao M, et al. Diastolic blood pressure and intensive blood pressure control on cognitive outcomes: insights from the SPRINT MIND trial. Hypertension. 2023;80(3):580\u20139.","journal-title":"Hypertension"},{"issue":"3","key":"1343_CR75","doi-asserted-by":"publisher","first-page":"e213334","DOI":"10.1212\/WNL.0000000000213334","volume":"104","author":"DM Reboussin","year":"2025","unstructured":"Reboussin DM, Gaussoin SA, Pajewski NM, Jaeger BC, Sachs B, Rapp SR, et al. Long-term effect of intensive vs standard blood pressure control on mild cognitive impairment and probable dementia in SPRINT. Neurology. 2025;104(3):e213334.","journal-title":"Neurology"},{"issue":"5","key":"1343_CR76","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jamaneurol.2021.0178","volume":"78","author":"IM Nasrallah","year":"2021","unstructured":"Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB, et al. Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of alzheimer disease: secondary analysis of the SPRINT MIND randomized trial. JAMA Neurol. 2021;78(5):568\u201377.","journal-title":"JAMA Neurol"},{"issue":"6","key":"1343_CR77","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/s41591-025-03616-8","volume":"31","author":"J He","year":"2025","unstructured":"He J, Zhao C, Zhong S, Ouyang N, Sun G, Qiao L, et al. Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial. Nat Med. 2025;31(6):2054\u201361.","journal-title":"Nat Med"},{"issue":"1","key":"1343_CR78","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","volume":"76","author":"YN Ou","year":"2020","unstructured":"Ou YN, Tan CC, Shen XN, Xu W, Hou XH, Dong Q, et al. Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies. Hypertension. 2020;76(1):217\u201325.","journal-title":"Hypertension"},{"key":"1343_CR79","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison HC, et al. 2017 acc\/aha\/aapa\/abc\/acpm\/ags\/apha\/ash\/aspc\/nma\/pcna guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. JACC. 2018;71(19):e127\u2013248.","DOI":"10.1016\/j.jacc.2017.11.006"},{"issue":"6","key":"1343_CR80","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1161\/STR.0000000000000431","volume":"54","author":"C Iadecola","year":"2023","unstructured":"Iadecola C, Smith EE, Anrather J, Gu C, Mishra A, Misra S, et al. The neurovasculome: key roles in brain health and cognitive impairment: A scientific statement from the American Heart Association\/American Stroke Association. Stroke. 2023;54(6):e251-71.","journal-title":"Stroke"},{"issue":"6","key":"1343_CR81","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","volume":"68","author":"C Iadecola","year":"2016","unstructured":"Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, et al. Impact of hypertension on cognitive function: a scientific statement from the American heart association. Hypertension. 2016;68(6):e67-94.","journal-title":"Hypertension"},{"issue":"1","key":"1343_CR82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","volume":"19","author":"J Ding","year":"2020","unstructured":"Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, et al. Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 2020;19(1):61\u201370.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1343_CR83","doi-asserted-by":"publisher","first-page":"e2333353","DOI":"10.1001\/jamanetworkopen.2023.33353","volume":"6","author":"MJ Lennon","year":"2023","unstructured":"Lennon MJ, Lam BCP, Lipnicki DM, Crawford JD, Peters R, Schutte AE, et al. Use of antihypertensives, blood pressure, and estimated risk of dementia in late life: an individual participant data meta-analysis. JAMA Netw Open. 2023;6(9):e2333353.","journal-title":"JAMA Netw Open"},{"issue":"21","key":"1343_CR84","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1212\/WNL.0000000000007543","volume":"92","author":"R Peters","year":"2019","unstructured":"Peters R, Warwick J, Anstey KJ, Anderson CS. Blood pressure and dementia. Neurology. 2019;92(21):1017\u20138.","journal-title":"Neurology"},{"issue":"1","key":"1343_CR85","doi-asserted-by":"publisher","first-page":"e2145319","DOI":"10.1001\/jamanetworkopen.2021.45319","volume":"5","author":"ZA Marcum","year":"2022","unstructured":"Marcum ZA, Cohen JB, Zhang C, Derington CG, Greene TH, Ghazi L, et al. Association of antihypertensives that stimulate vs inhibit types 2 and 4 angiotensin II receptors with cognitive impairment. JAMA Netw Open. 2022;5(1):e2145319.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"1343_CR86","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1474-4422(20)30356-2","volume":"19","author":"PB Gorelick","year":"2020","unstructured":"Gorelick PB, Sorond F. Cognitive function in SPRINT: where do we go next? Lancet Neurol. 2020;19(11):880\u20131.","journal-title":"Lancet Neurol"},{"key":"1343_CR87","doi-asserted-by":"crossref","unstructured":"Li J, Li J. Trends, inequalities, and cross-location similarities in global dementia burden and attributable risk factors across 204 countries and territories (1990\u20132021) a systematic analysis for the global burden of disease study 2021. Int J Surg. 2025;10\u20131097.","DOI":"10.1097\/JS9.0000000000002628"},{"key":"1343_CR88","doi-asserted-by":"publisher","unstructured":"Yoon CH, Groff C, Criss O, Lecanemab. A second in class therapy for the management of early alzheimer\u2019s disease. Innov Pharm. 2024;15(1). https:\/\/doi.org\/10.24926\/iip.v15i1.5787.","DOI":"10.24926\/iip.v15i1.5787"},{"issue":"7618","key":"1343_CR89","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"issue":"6","key":"1343_CR90","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.0008","volume":"321","author":"K Yaffe","year":"2019","unstructured":"Yaffe K. Prevention of cognitive impairment with intensive systolic blood pressure control. JAMA. 2019;321(6):548\u20139.","journal-title":"JAMA"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01343-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-025-01343-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01343-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:03:06Z","timestamp":1770476586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-025-01343-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1007\/s11906-025-01343-6","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies on human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"24"}}